Jan 16 (Reuters) - Allakos Inc ALLK.O :
* ALLAKOS ANNOUNCES A RESTRUCTURING TO FOCUS ON DEVELOPMENT
OF
AK006
* ALLAKOS INC - COMPANY'S CASH RUNWAY IS EXPECTED TO EXTEND
INTO
MID-2026
* ALLAKOS INC - COMPANY WILL REDUCE ITS WORKFORCE BY
APPROXIMATELY
50%
* ALLAKOS INC - COMPANY WILL HALT LIRENTELIMAB-RELATED
ACTIVITIES
ACROSS CLINICAL, MANUFACTURING, RESEARCH AND ADMINISTRATIVE
FUNCTION
* ALLAKOS INC - ANTICIPATES THAT SIGNIFICANT MAJORITY OF
RESTRUCTURING EXPENDITURES WILL BE PAID IN FIRST HALF OF 2024
Source text for Eikon: ID:nGNX8KfwXw
Further company coverage: ALLK.O
((Reuters.Briefs@thomsonreuters.com;))